Business Description
Aura Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US05153U1079
Description
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.14 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -24.6 | |||||
| 3-Year EPS without NRI Growth Rate | -19.5 | |||||
| 3-Year FCF Growth Rate | -8.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.92 | |||||
| 9-Day RSI | 44.74 | |||||
| 14-Day RSI | 44.32 | |||||
| 6-1 Month Momentum % | 42.61 | |||||
| 12-1 Month Momentum % | 33.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.47 | |||||
| Quick Ratio | 12.47 | |||||
| Cash Ratio | 11.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.1 | |||||
| Shareholder Yield % | 0.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.68 | |||||
| ROA % | -38.05 | |||||
| ROIC % | -308.79 | |||||
| ROC (Joel Greenblatt) % | -410.57 | |||||
| ROCE % | -44.96 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.65 | |||||
| Price-to-Tangible-Book | 2.65 | |||||
| EV-to-EBIT | -3.33 | |||||
| EV-to-EBITDA | -3.37 | |||||
| EV-to-FCF | -4.16 | |||||
| Price-to-Net-Current-Asset-Value | 3.03 | |||||
| Price-to-Net-Cash | 3.22 | |||||
| Earnings Yield (Greenblatt) % | -30.03 | |||||
| FCF Yield % | -16.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AURA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aura Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.73 | ||
| Beta | 0.37 | ||
| Volatility % | 57.44 | ||
| 14-Day RSI | 44.32 | ||
| 14-Day ATR ($) | 0.486073 | ||
| 20-Day SMA ($) | 9.7975 | ||
| 12-1 Month Momentum % | 33.04 | ||
| 52-Week Range ($) | 6.63 - 12.3782 | ||
| Shares Outstanding (Mil) | 49.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aura Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aura Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aura Biosciences Inc Frequently Asked Questions
What is Aura Biosciences Inc(AURA)'s stock price today?
The current price of AURA is $9.31. The 52 week high of AURA is $12.38 and 52 week low is $6.63.
When is next earnings date of Aura Biosciences Inc(AURA)?
The next earnings date of Aura Biosciences Inc(AURA) is 2025-02-12 Est..
Does Aura Biosciences Inc(AURA) pay dividends? If so, how much?
Aura Biosciences Inc(AURA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers